Latest News and Press Releases

NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused sales, trading & investment banking firm, is pleased to announce it will host its 3rd Annual...

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused sales, trading & investment banking firm announced today a significant expansion of its equity...

NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Discovery One on One Virtual Investor Conference on Wednesday, November 18th, 2020. The...

NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual One on One Technology Investor Conference on Thursday, November 12th, 2020. The...

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual 1x1 “Healthcare House Call” Investor Conference June 15-16th.  The conference features...

NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares...

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on May 22nd of a Registered Direct Offering of 10,666,666 shares of common stock of Cinedigm Corp. (NASDAQ:...

NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing on March 16th of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 7,500,000 shares of...

NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...

NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...